Spartan Bioscience Inc.
March 04, 2008 08:01 ET
Spartan Bioscience Donates DNA Analyzer to The Ottawa Hospital
Equipment will provide STAT results in molecular microbiology research
OTTAWA, ONTARIO--(Marketwire - March 4, 2008) - Spartan Bioscience Inc., a Canadian molecular diagnostics company that develops, manufactures, and markets DNA analyzers for on-demand applications, today announced a significant donation in equipment, the Spartan DX™ real-time PCR (Polymerase Chain Reaction) DNA analyzer, to The Ottawa Hospital.
"The Spartan DX is a new instrument in the realm of molecular diagnostics. It offers speed and flexibility and in my opinion it will be ideal for use in diagnostic laboratories to develop assays that, in the future, may be used for clinical diagnostic purposes. For similar reasons, it will also be a valuable tool in research laboratories," said Dr. Karam Ramotar, (PhD), Molecular Microbiologist at The Ottawa Hospital. "In Clinical diagnostic laboratories, I can see the Spartan DX playing a major role in providing non-batched ('stat') molecular testing, thus expanding the repertoire of testing in these laboratories. It provides rapid and reliable results comparable to similar instruments and the assays are easily incorporated in laboratories that already perform molecular testing."
The Spartan DX is designed for non-batched, on-demand DNA applications where speed and convenience are important. Applications include low-throughput research experiments and non-batched testing for infectious diseases. The Spartan DX has been validated against industry-leading real-time PCR machines. It is proven to be compatible with industry-standard consumables, including inexpensive reaction tubes and real-time PCR reagents and kits from leading manufacturers.
"We donated a Spartan DX because we recognize the value of supporting the research efforts of The Ottawa Hospital. The Division of Microbiology has been a key partner in validating the instrument and demonstrating its usefulness for on-demand DNA testing," said Dr. Paul Lem, CEO and Founder of Spartan Bioscience. "Spartan is creating a new market for on-demand molecular diagnostics. There is enormous potential for rapid and highly accurate DNA results to benefit hospitals around the world. We will continue to collaborate with microbiologists at The Ottawa Hospital to develop DNA devices that are fast, affordable and easy to use."
About Spartan Bioscience
Founded in 2005, Spartan Bioscience Inc. is a privately-held molecular diagnostics company that develops, manufactures, and markets DNA analyzers for on-demand applications. The company is focusing on applications where rapid and convenient DNA testing is particularly important, such as low-throughput research experiments and non-batched testing for infectious diseases.